retatrutide liver Triple hormone receptor agonist for metabolic dysfunction-associated steatotic disease: a randomized phase 2a trial retatrutide nonalcoholic fatty liver disease

(and we all can attest to the major time drain and headache we all go through in trying to get guideline-recommended medications to our patients.) To view or add a comment, sign in 503 followers

common: mild nausea (10%), injection site redness

152 Infusions of bombesin and GRP decrease food intake in humans by enhancing satiety, although effective doses of bombesin may induce nausea and decrease food palatability

If you can drop certain particularly stressful obligations in your life then this would be a great time to do so

One of the tools that you may have read a lot about recently is a class of medications called GLP-1s

Timing: Inject at consistent times